globalnews.ca
69%
636
Pfizer expects US$15 billion in sales from coronavirus vaccine this year
Pfizer Inc said on Tuesday it expects to generate US$15 billion, or about a quarter of its total revenue this year, from the sale of its COVID-19 vaccine co-developed with German partner BioNTech.The drugmaker is striving to deliver two billion doses of the vaccine in 2021 at a breakneck pace as countries rush to sign supply deals in an effort to control a pandemic that has killed over 2 million people globally.Pfizer said its forecast could go higher if the company signs more supply contracts.“2021 earnings and sales will see a significant benefit from the vaccine, and this benefit could increase throughout the year,” said Edward Jones analyst Ashtyn Evans.